Arrowpoint Investment Partners (Singapore) Pte. Ltd. Natera, Inc. Transaction History
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
- $487 Billion
- Q4 2024
A detailed history of Arrowpoint Investment Partners (Singapore) Pte. Ltd. transactions in Natera, Inc. stock. As of the latest transaction made, Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds 18,578 shares of NTRA stock, worth $3.12 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
18,578Holding current value
$3.12 Million% of portfolio
0.6%Shares
1 transactions
Others Institutions Holding NTRA
# of Institutions
634Shares Held
123MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$2.07 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.14 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$1.13 Billion0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$1.13 Billion0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$745 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...